Publication: Clinical use of erythromycin in children with gastrointestinal dysmotility
1
Issued Date
2001-07-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0035685799
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.84, No.7 (2001), 1021-1026
Suggested Citation
Prapun Aanpreung, Chirasri Vajaradul Clinical use of erythromycin in children with gastrointestinal dysmotility. Journal of the Medical Association of Thailand. Vol.84, No.7 (2001), 1021-1026. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26746
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Clinical use of erythromycin in children with gastrointestinal dysmotility
Author(s)
Other Contributor(s)
Abstract
Intolerant feeding is a common symptom in gastrointestinal disorders which is commonly found in systemic diseases. Prokinetic drugs play a role in management. A low dose of erythromycin has an effect on improvement of antroduodenal motility and gastric emptying in children and adults. The objective of this study was to evaluate the efficacy of intravenous erythromycin in the treatment of GI dysmotility in children. Retrospective studies were performed in the Department of Pediatrics, Siriraj Hospital, Mahidol University between 1996 and 2000 in 22 patients with intolerance of feeding due to GI dysmotility. Their ages ranged from 11 days to 12 years (42.1 ± 48.1 months). The patients were divided into 2 groups: 12 critically ill and 10 non-critically ill patients. Dosages of intravenous erythromycin were 1-3 mg/kg/dose every 6 hours. The result of treatment was evaluated as: good (tolerant feeding), fair (tolerant feeding but needing erythromycin for longer than 1 month) and failed (intolerant feeding). All non-critically ill patients had improved symptoms with 9 ± 4.3 days duration of treatment. In the other group, 8 patients had good results with 10.9 ± 6 days of treatment. Two patients needed the drug for longer than 1 month and the other 2 patients did not respond and died due to severe infection. Low dose intravenous erythromycin had good efficacy in the treatment of intolerant feeding related to GI dysmotility in children.